Literature DB >> 33232269

Identification of prognostic chromatin-remodeling genes in clear cell renal cell carcinoma.

Yujing Yang1, Chengyuan Wang2, Ningde Wei2, Ting Hong2, Zuyu Sun2, Jiawen Xiao3, Jiaxi Yao2, Zhi Li1, Tao Liu2.   

Abstract

The aim of this study was to investigate the effects of chromatin-remodeling genes on the prognosis of patients with clear cell renal cell carcinoma (ccRCC). In TCGA-KIRC patients, two subgroups based on 86 chromatin-remodeling genes were established. The random forest algorithm was used for feature selection to identify BPTF, SIN3A and CNOT1 as characterized chromatin remodelers in ccRCC with good prognostic value. YY1 was indicated to be a transcription factor of genes highly related to BPTF, SIN3A and CNOT1. Functional annotations indicated that BPTF, SIN3A, CNOT1 and YY1 are all involved in the ubiquitin-mediated proteolysis process and that high expression of any of the five associated E3 ubiquitin ligases found in the pathway suggests a good prognosis. Protein network analysis indicated that BPTF has a targeted regulatory effect on YY1. Another independent dataset from International Cancer Genome Consortium (ICGC) showed a strong consistency with results in TCGA. In conclusion, we demonstrate that BPTF, SIN3A and CNOT1 are novel prognostic factors that predict good survival in ccRCC. We predicted that the good prognostic value of chromatin-remodeling genes BPTF and SIN3A is related to the regulation of YY1 and that YY1 regulates E3 ubiquitin ligases for further degradation of oncoproteins in ccRCC.

Entities:  

Keywords:  BPTF; SIN3A; chromatin-remodeling genes; clear cell renal cell carcinoma (ccRCC); prognostic biomarkers

Mesh:

Year:  2020        PMID: 33232269      PMCID: PMC7803503          DOI: 10.18632/aging.104170

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  67 in total

1.  The SIN3 deacetylase complex represses genes encoding mitochondrial proteins: implications for the regulation of energy metabolism.

Authors:  Lori A Pile; Paul T Spellman; Rebeccah J Katzenberger; David A Wassarman
Journal:  J Biol Chem       Date:  2003-07-15       Impact factor: 5.157

2.  Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks.

Authors:  Paul Blanche; Jean-François Dartigues; Hélène Jacqmin-Gadda
Journal:  Stat Med       Date:  2013-09-12       Impact factor: 2.373

3.  Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.

Authors:  Diana Miao; Claire A Margolis; Wenhua Gao; Martin H Voss; Wei Li; Dylan J Martini; Craig Norton; Dominick Bossé; Stephanie M Wankowicz; Dana Cullen; Christine Horak; Megan Wind-Rotolo; Adam Tracy; Marios Giannakis; Frank Stephen Hodi; Charles G Drake; Mark W Ball; Mohamad E Allaf; Alexandra Snyder; Matthew D Hellmann; Thai Ho; Robert J Motzer; Sabina Signoretti; William G Kaelin; Toni K Choueiri; Eliezer M Van Allen
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

4.  Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.

Authors:  Eduardo F Farias; Kevin Petrie; Boris Leibovitch; Janice Murtagh; Manuel Boix Chornet; Tino Schenk; Arthur Zelent; Samuel Waxman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

5.  PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.

Authors:  Yubo Zhao; Yunfei Wang; Enyang Zhao; Yanli Tan; Bo Geng; Chunsheng Kang; Xuedong Li
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.944

6.  Transcription factor YY1 is essential for regulation of the Th2 cytokine locus and for Th2 cell differentiation.

Authors:  Soo Seok Hwang; Young Uk Kim; Sumin Lee; Sung Woong Jang; Min Kyung Kim; Byung Hee Koh; Wonyong Lee; Joomyeong Kim; Abdallah Souabni; Meinrad Busslinger; Gap Ryol Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

7.  BAP1 loss defines a new class of renal cell carcinoma.

Authors:  Samuel Peña-Llopis; Silvia Vega-Rubín-de-Celis; Arnold Liao; Nan Leng; Andrea Pavía-Jiménez; Shanshan Wang; Toshinari Yamasaki; Leah Zhrebker; Sharanya Sivanand; Patrick Spence; Lisa Kinch; Tina Hambuch; Suneer Jain; Yair Lotan; Vitaly Margulis; Arthur I Sagalowsky; Pia Banerji Summerour; Wareef Kabbani; S W Wendy Wong; Nick Grishin; Marc Laurent; Xian-Jin Xie; Christian D Haudenschild; Mark T Ross; David R Bentley; Payal Kapur; James Brugarolas
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

8.  Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.

Authors:  Jiaming Su; Yi Sui; Jian Ding; Fuqiang Li; Shuang Shen; Yang Yang; Zeming Lu; Fei Wang; Lingling Cao; Xiaoxia Liu; Jingji Jin; Yong Cai
Journal:  Protein Cell       Date:  2016-08-17       Impact factor: 14.870

9.  YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment.

Authors:  Jonathan A Beagan; Michael T Duong; Katelyn R Titus; Linda Zhou; Zhendong Cao; Jingjing Ma; Caroline V Lachanski; Daniel R Gillis; Jennifer E Phillips-Cremins
Journal:  Genome Res       Date:  2017-05-23       Impact factor: 9.043

10.  Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.

Authors:  Pooja Ghatalia; Eddy S Yang; Brittany N Lasseigne; Ryne C Ramaker; Sara J Cooper; Dongquan Chen; Sunil Sudarshan; Shi Wei; Arjun S Guru; Amy Zhao; Tiffiny Cooper; Deborah L Della Manna; Gurudatta Naik; Richard M Myers; Guru Sonpavde
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

View more
  2 in total

1.  Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma.

Authors:  Yusa Chen; Yumei Liang; Ying Chen; Shaxi Ouyang; Kanghan Liu; Wei Yin
Journal:  J Oncol       Date:  2021-09-27       Impact factor: 4.375

2.  Integrated Analysis of miRNA and mRNA Expression Profiles Reveals the Molecular Mechanism of Posttraumatic Stress Disorder and Therapeutic Drugs.

Authors:  Chunchun Gan; Zhan Jin; Gaobo Hu; Zheming Li; Minli Yan
Journal:  Int J Gen Med       Date:  2022-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.